10 results

e45 Impact on survival with adjuvant radiotherapy for clear cell, mucinous, and endometriod ovarian cancer: the SEER experience from 2004 to 2011
Sagar C. Patel, Jonathan Frandsen, Sudershan Bhatia, David Gaffney
KMSID: 1093769   J Gynecol Oncol. 2016;27(5):e45.  Published online 2016 May 3    DOI: http://dx.doi.org/10.3802/jgo.2016.27.e45
         
e46 Comparison of survival outcomes after recurrence detected by cancer antigen 125 elevation versus imaging study in epithelial ovarian cancer
E Sun Paik, Tae-Joong Kim, Yoo-Young Lee, Chel Hun Choi, Jeong-Won Lee, Byoung-Gie Kim, Duk-Soo Bae
KMSID: 1093770   J Gynecol Oncol. 2016;27(5):e46.  Published online 2016 May 9    DOI: http://dx.doi.org/10.3802/jgo.2016.27.e46
         
e47 Bevacizumab toxicity in heavily pretreated recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancers
Jovana Y. Martin, Renata R. Urban, John B. Liao, Barbara A. Goff
KMSID: 1093771   J Gynecol Oncol. 2016;27(5):e47.  Published online 2016 May 10    DOI: http://dx.doi.org/10.3802/jgo.2016.27.e47
         
e48 Clinical outcomes of stage I endometrial carcinoma patients treated with surgery alone: Siriraj Hospital experiences
Suwanit Therasakvichya, Sompop Kuljarusnont, Janjira Petsuksiri, Pattama Chaopotong, Vuthinun Achariyapota, Pisutt Srichaikul, Atthapon Jaishuen
KMSID: 1093772   J Gynecol Oncol. 2016;27(5):e48.  Published online 2016 May 16    DOI: http://dx.doi.org/10.3802/jgo.2016.27.e48
         
e49 Associations between sexually transmitted infections, high-risk human papillomavirus infection, and abnormal cervical Pap smear results in OB/GYN outpatients
Hye-Sun Kim, Tae Jin Kim, In-Ho Lee, Sung Ran Hong
KMSID: 1093773   J Gynecol Oncol. 2016;27(5):e49.  Published online 2016 May 16    DOI: http://dx.doi.org/10.3802/jgo.2016.27.e49
         
e50 The 15th Chinese Society of Gynecologic Oncology National Conference and the 6th Southern China Ovarian Cancer Summit, March 10–13, 2016, Guangzhou
Ashvin Soochit, Chuyao Zhang, Jihong Liu
KMSID: 1093775   J Gynecol Oncol. 2016;27(5):e50.  Published online 2016 September 4    DOI: http://dx.doi.org/10.3802/jgo.2016.27.e50
         
e51 Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research
Sung-Jong Lee, Andrew Yang, T.-C. Wu, Chien-Fu Hung
KMSID: 1094335   J Gynecol Oncol. 2016;27(5):e51.  Published online 2016 May 31    DOI: http://dx.doi.org/10.3802/jgo.2016.27.e51
         
e52 Neoadjuvant chemotherapy followed by surgery has no therapeutic advantages over concurrent chemoradiotherapy in International Federation of Gynecology and Obstetrics stage IB-IIB cervical cancer
Jeongshim Lee, Tae Hyung Kim, Gwi Eon Kim, Ki Chang Keum, Yong Bae Kim
KMSID: 1093777   J Gynecol Oncol. 2016;27(5):e52.  Published online 2016 June 8    DOI: http://dx.doi.org/10.3802/jgo.2016.27.e52
         
e54 Identification of appropriate cone length to avoid positive cone margin in high grade cervical intraepithelial neoplasia
Kouichiro Kawano, Naotake Tsuda, Shin Nishio, Koji Yonemoto, Kazuto Tasaki, Rurika Tasaki, Kimio Ushijima
KMSID: 1093779   J Gynecol Oncol. 2016;27(5):e54.  Published online 2016 June 22    DOI: http://dx.doi.org/10.3802/jgo.2016.27.e54
         
e50 The 15th Chinese Society of Gynecologic Oncology National Conference and the 6th Southern China Ovarian Cancer Summit, March 10-13, 2016, Guangzhou
Ashvin Soochit, Chuyao Zhang, Jihong Liu
KMSID: 1148283   J Gynecol Oncol. 2016;27(5):e50.  Published online 2016 May 27    DOI: http://dx.doi.org/10.3802/jgo.2016.27.e50
         
Articles from Journal of Gynecologic Oncology are provided here courtesy of Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology